注册并分享邀请链接,可获得视频播放与邀请奖励。

Eli Lilly and Company
@EliLillyandCo
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad) 
加入 July 2010
1.2K 正在关注    147.2K 粉丝
Presented at #EASD2026#, our investigational combination of a selective amylin agonist and GIP/GLP-1 receptor agonist showed promising results in adults with obesity and type 2 diabetes: substantial weight loss and A1C reduction. Read more:
显示更多